Submitted by Anonymous (not verified) on 14 July 2026 - 13:15
Human medicines European public assessment report (EPAR): Zefylti, filgrastim, Date of authorisation: 12/02/2025, Revision: 3, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Zefylti, filgrastim, Date of authorisation: 12/02/2025, Revision: 3, Status: Authorised